A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.
The U.S. Food and Drug Administration approved Eli Lilly’s drug, named Zepbound. The drug, also known as tirzepatide, helped dieters lose as much as 40 to 60 pounds in testing.
I’m upvoting you and I’m going to share your story with others but unfortunately I know this isn’t the case with me, as I was adult diagnosis ADHD and dealt with the hypoglycemia since elementary school. I only tried stimulant medication for the first time two years ago.
But I wonder if any studies have been done about frequency of ADHD and hypoglycemia comorbidities! Seems promising!